The Covid-19 pandemic has thrown up opportunities for Indian companies to collaborate with their global counterparts to design and manufacture world-class products with international certification. Max Ventilator, an Indian ventilator manufacturer has done just that. It has signed a technology collaboration agreement with Amptron Medical, a US-based respiratory technology company.

With this collaboration, Max aims to make products that adhere to international quality standards and obtain global certification thereby enhance its product profile.

In the recent past, Max and Amptron Medical had developed High Flow Oxygen Therapy (HFOT), a device that’s reliable and cost-effective compared to a traditional ventilator. This emerged as a choice for hospitals during Covid-19.

According to Ashok Patel, founder, Max Ventilator, ``Until now, Indian products were limited to having Indian certifications. This also curtailed access to international markets for their products. However, with this joint venture with Amptron, Max intends to go truly global in its manufacturing outlook and approach to expand our presence in developed markets. With Amptron’s cutting edge technology expertise in the medical devices space, we are confident that this collaboration will give a new impetus to Max’s global vision and ambition while also adding strength to India’s quest for becoming a world-class manufacturer of ventilators and other medical devices.’’

Speaking on the collaboration Nirav Patel, CEO, Amptron Medical said, “With Max’s decades of medical technology-based product development experience and extensive on-the-ground market experience, this collaboration will give Amptron Medical the market access and reach it desires. We are confident that Max Ventilator will prove to be a valued partner in that regard.